Drug recall D-0732-2026
Product
Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-401-10.
Reason for recall
Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.
Lots and codes
Lots: GY825029, GY825030, GY825031, GY825032, expires: 2028-OCT
Recall details
- Recalling firm
- JB Chemicals and Pharmaceuticals Ltd, Mumbai, N/A
- Quantity
- 34,020 100-count bottles.
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- June 24, 2026
Related products
- Cetirizine hydrochloride – drug information
- NDC 16571-401 Cetirizine Hydrochloride · Cetirizine Hydrochloride 5 mg/1 · Rising Pharma Holdings, Inc.